DD120192A5 - - Google Patents

Info

Publication number
DD120192A5
DD120192A5 DD187639A DD18763975A DD120192A5 DD 120192 A5 DD120192 A5 DD 120192A5 DD 187639 A DD187639 A DD 187639A DD 18763975 A DD18763975 A DD 18763975A DD 120192 A5 DD120192 A5 DD 120192A5
Authority
DD
German Democratic Republic
Application number
DD187639A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD120192A5 publication Critical patent/DD120192A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
DD187639A 1974-08-05 1975-08-01 DD120192A5 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438020A DE2438020A1 (de) 1974-08-05 1974-08-05 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DD120192A5 true DD120192A5 (enExample) 1976-06-05

Family

ID=5922668

Family Applications (1)

Application Number Title Priority Date Filing Date
DD187639A DD120192A5 (enExample) 1974-08-05 1975-08-01

Country Status (17)

Country Link
US (1) US4029777A (enExample)
JP (1) JPS5141347A (enExample)
AT (1) AT345998B (enExample)
BE (1) BE832124A (enExample)
CA (1) CA1037027A (enExample)
CH (1) CH611910A5 (enExample)
CS (2) CS175500B2 (enExample)
DD (1) DD120192A5 (enExample)
DE (1) DE2438020A1 (enExample)
DK (1) DK136369C (enExample)
ES (1) ES439720A1 (enExample)
FR (1) FR2281123A1 (enExample)
GB (1) GB1512258A (enExample)
HU (1) HU171684B (enExample)
IL (1) IL47770A (enExample)
NL (1) NL7509326A (enExample)
SE (1) SE404804B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61144199A (ja) * 1984-12-18 1986-07-01 Pioneer Electronic Corp スピ−カ用紙製振動部材の製造方法
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
WO1989002272A1 (en) * 1987-08-25 1989-03-23 Gee Kelvin W Compositions and methods for alleviating stress, anxiety and seizure activity
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
WO2014169832A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
MX362543B (es) 2013-04-17 2019-01-24 Sage Therapeutics Inc Esteroides c21-n-pirazolilo 19-nor c3,3- disustituidos y metodos de uso de los mismos.
HRP20210610T1 (hr) 2013-07-19 2021-05-28 Sage Therapeutics, Inc. Neuroaktivni steroidi, pripravci i njihove uporabe
PT3035940T (pt) 2013-08-23 2019-01-28 Sage Therapeutics Inc Esteroides neuroativos, composições e seus usos
WO2015195962A1 (en) 2014-06-18 2015-12-23 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP4275748A3 (en) 2014-10-16 2024-01-03 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders
EP3885352B1 (en) 2014-10-16 2024-11-27 Sage Therapeutics, Inc. A compound, compositions thereof and this compound for use in methods of treating cns disorders
RS60343B1 (sr) 2014-11-27 2020-07-31 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
SMT202100113T1 (it) 2015-01-26 2021-05-07 Sage Therapeutics Inc Composizioni e metodi per trattare disturbi del snc
EP3258939B1 (en) 2015-02-20 2022-09-07 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
AU2017296295B2 (en) 2016-07-11 2022-02-24 Sage Therapeutics, Inc. C7, C12, and C16 substituted neuroactive steroids and their methods of use
CN118271387A (zh) * 2017-12-22 2024-07-02 萨奇治疗股份有限公司 治疗cns疾病的组合物和方法
AR119047A1 (es) 2019-05-31 2021-11-17 Sage Therapeutics Inc Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1409239A (en) * 1971-11-11 1975-10-08 Glaxo Lab Ltd Process for the preparation of 3alpha-hydroxy-5alpha-steroids
BE791196A (fr) * 1971-11-11 1973-05-10 Glaxo Lab Ltd Nouveaux steroides, leur procede de preparation et leurs applications

Also Published As

Publication number Publication date
AU8351575A (en) 1977-02-03
GB1512258A (en) 1978-05-24
US4029777A (en) 1977-06-14
IL47770A0 (en) 1975-10-15
JPS5141347A (en) 1976-04-07
AT345998B (de) 1978-10-10
NL7509326A (nl) 1976-02-09
CS175498B2 (enExample) 1977-05-31
DE2438020A1 (de) 1976-02-26
DK344475A (da) 1976-02-06
ES439720A1 (es) 1977-03-01
CA1037027A (en) 1978-08-22
IL47770A (en) 1978-10-31
BE832124A (fr) 1976-02-05
HU171684B (hu) 1978-02-28
SE404804B (sv) 1978-10-30
CS175500B2 (enExample) 1977-05-31
FR2281123A1 (fr) 1976-03-05
ATA600475A (de) 1978-02-15
DK136369C (da) 1978-02-27
CH611910A5 (enExample) 1979-06-29
DK136369B (da) 1977-10-03
SE7508777L (sv) 1976-02-06

Similar Documents

Publication Publication Date Title
CS175498B2 (enExample)
FR2256937A1 (enExample)
FI751987A7 (enExample)
FR2259535B3 (enExample)
FR2257420B1 (enExample)
AU6717074A (enExample)
AU7463174A (enExample)
BG19726A1 (enExample)
BG20458A1 (enExample)
BG19770A1 (enExample)
BG19766A1 (enExample)
BG20665A1 (enExample)
BG19716A1 (enExample)
BG19668A1 (enExample)
BG19662A1 (enExample)
BG20662A1 (enExample)
BG19453A1 (enExample)
BE859807Q (enExample)
BE836321A (enExample)
BE832276A (enExample)
BE525532A (enExample)
AU7504272A (enExample)
BG19886A1 (enExample)
BG19892A1 (enExample)
DD120844A5 (enExample)